Comparative Pharmacology
Head-to-head clinical analysis: BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE versus CORTIFOAM.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE versus CORTIFOAM.
BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE vs CORTIFOAM
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Betamethasone acetate and betamethasone sodium phosphate are corticosteroids that bind to the glucocorticoid receptor, leading to modulation of gene expression and suppression of inflammatory mediators such as prostaglandins and leukotrienes. They inhibit phospholipase A2, reduce cytokine production, and decrease immune cell migration and activation.
Cortifoam (hydrocortisone acetate) is a corticosteroid that binds to glucocorticoid receptors, modulating gene expression to induce anti-inflammatory, antipruritic, and vasoconstrictive effects. It inhibits phospholipase A2, reducing prostaglandin and leukotriene synthesis, and suppresses immune cell migration and cytokine release.
1-4 mg (of betamethasone base) IM or IV every 12-24 hours, tapering as clinically indicated.
1 applicatorful (90 mg hydrocortisone acetate) rectally twice daily for 2-3 weeks, then every other day as needed.
None Documented
None Documented
The terminal elimination half-life of betamethasone is approximately 6.5 hours (range 4-8 hours) in plasma. This corresponds to a biological half-life of 36-54 hours for anti-inflammatory effects due to receptor occupancy and downstream effects. Clinical dosing intervals are typically 12-24 hours for sustained effect.
Approximately 1.5-2 hours for hydrocortisone; clinically, effects persist longer due to local action.
Betamethasone and its metabolites are excreted primarily in urine (80-90%), with less than 10% in feces via biliary excretion. Approximately 25% is excreted unchanged. Renal clearance involves glomerular filtration and tubular reabsorption.
Primarily renal (about 70-90% as metabolites) and fecal (about 10-30% as metabolites).
Category D/X
Category C
Corticosteroid
Corticosteroid